Research & Launch Strategy
From Pre-Clinical Development to Post-Launch Optimization
Research that Powers Every Stage
Bringing a new therapy to market is complex. From early-stage development through post-launch optimization, we help Pharmaceuticals and Biotech manufacturers generate the insights needed to reduce risk, accelerate adoption, and maximize commercial success.
Key Benefits:
- Pre-Clinical & Early Development - Identify unmet patient needs and treatment gaps
- Preclinical Research & Regulatory Strategy - Understand payer and provider expectations
- Launch Readiness - Test positioning, messaging, and pricing with target audiences
- Post-Launch Optimization - Monitor adoption, brand perception, and competitive dynamics
The result: Confident launches, market leadership, and business growth.
Commercial Success
Commercial success depends on understanding the market, HCPs, and patients. We help navigate commercialization with insights that inform every stage and beyond.
Novenix can help you optimize pricing, drive HCP engagement, and support patient adoption through actionable research. We track competitive dynamics and monitor brand performance to maximize commercial impact.
The result: Faster adoption, stronger market presence, and sustained commercial growth.
Pricing Strategy
Entering the market after approval is just the beginning. Securing market access-pricing, reimbursement, and patient adoption-requires insights that go beyond clinical data.
We help pharma/biotech manufacturers generate the evidence payers and providers need, reduce access barriers, and optimize commercialization strategy. Our advanced pricing solutions-including Conjoint Analysis and MaxDiff-help you determine the optimal price point that balances market access, profitability, and patient affordability.
Research insights at this stage are critical to:
- Payer negotiation and pricing strategy - Using Conjoint and MaxDiff to identify the optimal price-to-value ratio
- Reimbursement and coverage decisions - Quantifying clinical and economic value for payers
- HCP adoption and patient access - Understanding prescribing behavior and patient preferences
- Commercial success and market leadership - Data-driven decisions that maximize market potential